Allergic Rhinitis and its Impact on Asthma (ARIA) guidelines—2016 revision

Scientific publication - Journal Article
uoadl:3000988

Units

NKUA research material

Title

Allergic Rhinitis and its Impact on Asthma (ARIA) guidelines—2016 revision

Languages of Item

English

Abstract

Background: Allergic rhinitis (AR) affects 10% to 40% of the population. It reduces quality of life and school and work performance and is a frequent reason for office visits in general practice. Medical costs are large, but avoidable costs associated with lost work productivity are even larger than those incurred by asthma. New evidence has accumulated since the last revision of the Allergic Rhinitis and its Impact on Asthma (ARIA) guidelines in 2010, prompting its update. Objective: We sought to provide a targeted update of the ARIA guidelines. Methods: The ARIA guideline panel identified new clinical questions and selected questions requiring an update. We performed systematic reviews of health effects and the evidence about patients’ values and preferences and resource requirements (up to June 2016). We followed the Grading of Recommendations Assessment, Development, and Evaluation (GRADE) evidence-to-decision frameworks to develop recommendations. Results: The 2016 revision of the ARIA guidelines provides both updated and new recommendations about the pharmacologic treatment of AR. Specifically, it addresses the relative merits of using oral H1-antihistamines, intranasal H1-antihistamines, intranasal corticosteroids, and leukotriene receptor antagonists either alone or in combination. The ARIA guideline panel provides specific recommendations for the choice of treatment and the rationale for the choice and discusses specific considerations that clinicians and patients might want to review to choose the management most appropriate for an individual patient. Conclusions: Appropriate treatment of AR might improve patients’ quality of life and school and work productivity. ARIA recommendations support patients, their caregivers, and health care providers in choosing the optimal treatment. © 2017 American Academy of Allergy, Asthma & Immunology

Publication year

2017

Authors

Brożek, J.L. Bousquet, J. Agache, I. Agarwal, A. Bachert, C. Bosnic-Anticevich, S. Brignardello-Petersen, R. Canonica, G.W. Casale, T. Chavannes, N.H. Correia de Sousa, J. Cruz, A.A. Cuello-Garcia, C.A. Demoly, P. Dykewicz,...

More

Journal

Allergy: European Journal of Allergy and Clinical Immunology

Publisher

Mosby Year Book Inc

Volume

140

Number

4

Pages

950-958

Last modified

3 years ago

License

Creative Commons Attribution-NonCommercial 4.0 (CC-BY-NC)

Export Citation

This website uses cookies to enhance your user experience. By continuing to browse, you accept the use of cookies. More information: https://en.uoa.gr/about_us/personal_data_protection_policy